Search

everythinglearnresearchcommunity

for

Search:↓

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Certain patient characteristics can help predict hair regrowth success with ritlecitinib in alopecia areata.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

Hair loss due to scarring can be treated by reducing inflammation, removing scar tissue, and transplanting hair. The Follicular Unit Extraction technique is effective but requires skill and time. Future focus should be on scar-less healing methods.

A new treatment for hair loss uses tiny lipid carriers to deliver a mix of minoxidil and latanoprost directly to hair follicles, promoting hair growth and being well tolerated by the skin.

Prevent persistent hair loss after chemotherapy with scalp cooling and early minoxidil use.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

A man with total hair loss also developed a rare nail condition, likely due to autoimmune issues.

Nivolumab can cause hair loss as a rare side effect.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

The patient's hair loss was likely not caused by beta blockers but possibly by stress or other factors.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

New gene variants linked to a rare inherited hair loss disorder were found in three Chinese families.

Cetuximab can cause unusual hair growth and hair loss.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

Topical treatments for hair loss can be effective but need careful safety evaluation.

Genetic testing can diagnose hair loss linked to DSG4 gene variants.

Bimatoprost and clobetasol are both effective for scalp hair loss, but bimatoprost works faster, has fewer side effects, and grows more colored hair.

A woman with severe hair loss due to systemic sclerosis regrew her hair in 4 months using a combination of treatments.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.

Intralesional betamethasone and oral hydroxychloroquine improved hair loss in a woman with frontal fibrosing alopecia.

Stopping and restarting JAK inhibitors during pregnancy in women with alopecia areata leads to hair loss and regrowth, with most pregnancies resulting in healthy babies.

PRP is more effective than minoxidil and placebo for treating hair loss.